THE SHARE: Change: 0.00 SEK (0.00%) / Price: 0.11 SEK / Apr 17, 2026, 8:45 am (CEST)
  • Home
  • About
    • Introduction
    • Board of Directors
    • Management Team
    • Medical Advisors
    • Corporate Governance
    • Career
  • Technology
    • Physiological Targeting
    • Functional Nanoparticles
    • Publications
    • Patent
  • Portfolio
    • Pipeline
    • SpagoPix
    • Tumorad
  • Investor Relations
    • The Share
    • Analyst Coverage
    • Owners
    • Financial Reports
    • Financial Calendar
    • Equity research
    • Shareholder’s Personal Data
    • Share Issue
  • Media
    • Spago Nanomedical in media
    • Press Releases
    • Subscribe
    • Presentations
    • Events
    • Image Bank
  • Contact
    • Contact us

  • 10 Nov, 2016
    Spago Nanomedical presenterar på Stora Aktiedagen i Göteborg
  • 10 Nov, 2016
    Film från bolagspresentation vid Redeye Investor After Work i Stockholm 2016-11-08
  • 8 Nov, 2016
    Delårsrapport januari – september 2016
  • 29 Sep, 2016
    Film från bolagspresentation vid Redeye Investor Forum i Göteborg 2016-09-22
  • 21 Sep, 2016
    Spago Nanomedical presenterar på Redeye Investor Forum
  • 15 Sep, 2016
    Pilot study suggest role of MRI in primary screening for prostate cancer
  • 15 Sep, 2016
    Pilotstudie pekar på möjligheten att använda MRI-screening för prostatacancer
  • 26 Aug, 2016
    Interim report January – June 2016 (in Swedish)
  • 26 Aug, 2016
    Delårsrapport januari – juni 2016
  • 19 Aug, 2016
    Andreas Gram appointed Production Manager
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 36
  • Previous
  • Next
Back

About Spago Nanomedical

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of life-threatening and debilitating diseases.

Address

Spago Nanomedical AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

Phone: +46 46 811 88
LinkedIn

Member of:

Copyright © 2026 Spago Nanomedical AB. All Rights Reserved.
Design by Clavis Communications